Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host DiseaseRobert Zeiser, Gèrard Socié, Nikolas von Bubnoff et al.|New England Journal of Medicine|2020Cited by 859
Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC).Igor Resnick, Reuven Or, Allan I. Bloom et al.|PubMed|2013Cited by 118
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant RecipientsRoy F. Chemaly, Michael Boeckh, Sanjeet Dadwal et al.|Clinical Infectious Diseases|2019Cited by 75
Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemiaYishai Ofran, Avraham Frisch, Shimrit Ringelstein‐Harlev et al.|Leukemia|2019Cited by 69
Adult Nephrotic Syndrome after Hematopoietic Stem Cell Transplantation: Renal Pathology is the Best Predictor of Response to TherapyOfrat Beyar‐Katz, Yishai Ofran, Etty Kruzel Davila et al.|Biology of Blood and Marrow Transplantation|2015Cited by 50